These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 20660377)
21. Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT. Nurmi E; Ruottinen HM; Kaasinen V; Bergman J; Haaparanta M; Solin O; Rinne JO Ann Neurol; 2000 Jun; 47(6):804-8. PubMed ID: 10852547 [TBL] [Abstract][Full Text] [Related]
22. The influence of residual nor-β-CFT in 11C CFT injection on the Parkinson disease diagnosis: a 11C CFT PET study. Huang T; Wang H; Tang G; Liang X; Shi X; Zhang X Clin Nucl Med; 2012 Aug; 37(8):743-7. PubMed ID: 22785500 [TBL] [Abstract][Full Text] [Related]
23. Quantification of dopamine transporter by 123I-PE2I SPECT and the noninvasive Logan graphical method in Parkinson's disease. Prunier C; Payoux P; Guilloteau D; Chalon S; Giraudeau B; Majorel C; Tafani M; Bezard E; Esquerré JP; Baulieu JL J Nucl Med; 2003 May; 44(5):663-70. PubMed ID: 12732666 [TBL] [Abstract][Full Text] [Related]
24. The diagnostic value of minor salivary gland biopsy in clinically diagnosed patients with Parkinson's disease: comparison with DAT PET scans. Gao L; Chen H; Li X; Li F; Ou-Yang Q; Feng T Neurol Sci; 2015 Sep; 36(9):1575-80. PubMed ID: 25820147 [TBL] [Abstract][Full Text] [Related]
25. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography. Hsiao IT; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Lin KJ JAMA Neurol; 2014 Jun; 71(6):758-66. PubMed ID: 24756323 [TBL] [Abstract][Full Text] [Related]
26. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Pirker W Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046 [TBL] [Abstract][Full Text] [Related]
30. Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study. Strafella AP; Ko JH; Grant J; Fraraccio M; Monchi O Eur J Neurosci; 2005 Dec; 22(11):2946-52. PubMed ID: 16324129 [TBL] [Abstract][Full Text] [Related]
31. Neuroinflammation following anti-parkinsonian drugs in early Parkinson's disease: a longitudinal PET study. Terada T; Bunai T; Hashizume T; Matsudaira T; Yokokura M; Takashima H; Konishi T; Obi T; Ouchi Y Sci Rep; 2024 Feb; 14(1):4708. PubMed ID: 38409373 [TBL] [Abstract][Full Text] [Related]
32. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters. Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103 [TBL] [Abstract][Full Text] [Related]
33. SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys. Fischman AJ; Babich JW; Elmaleh DR; Barrow SA; Meltzer P; Hanson RN; Madras BK J Nucl Med; 1997 Jan; 38(1):144-50. PubMed ID: 8998169 [TBL] [Abstract][Full Text] [Related]
34. [18F]PR04.MZ PET/CT Imaging for Evaluation of Nigrostriatal Neuron Integrity in Patients With Parkinson Disease. Juri C; Kramer V; Riss PJ; Soza-Ried C; Haeger A; Pruzzo R; Rösch F; Amaral H; Chana-Cuevas P Clin Nucl Med; 2021 Feb; 46(2):119-124. PubMed ID: 33323728 [TBL] [Abstract][Full Text] [Related]
35. Neural correlates of standing imagery and execution in Parkinsonian patients: The relevance to striatal dopamine dysfunction. Mori Y; Yoshikawa E; Futatsubashi M; Ouchi Y PLoS One; 2020; 15(10):e0240998. PubMed ID: 33112886 [TBL] [Abstract][Full Text] [Related]
36. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834 [TBL] [Abstract][Full Text] [Related]
37. Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease. Rinne JO; Ruottinen H; Bergman J; Haaparanta M; Sonninen P; Solin O J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):737-41. PubMed ID: 10567489 [TBL] [Abstract][Full Text] [Related]
38. Extrastriatal dopaminergic changes in Parkinson's disease patients with impulse control disorders. Lee JY; Seo SH; Kim YK; Yoo HB; Kim YE; Song IC; Lee JS; Jeon BS J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):23-30. PubMed ID: 24023269 [TBL] [Abstract][Full Text] [Related]
39. In vivo presynaptic and postsynaptic striatal dopamine functions in idiopathic normal pressure hydrocephalus. Ouchi Y; Nakayama T; Kanno T; Yoshikawa E; Shinke T; Torizuka T J Cereb Blood Flow Metab; 2007 Apr; 27(4):803-10. PubMed ID: 16926840 [TBL] [Abstract][Full Text] [Related]